Know Labs, Inc. is a health care startup that aims to revolutionize non-invasive medical diagnostics. The company's proprietary technology platform utilizes radiofrequency (RF) dielectric spectroscopy and can be integrated into various wearable, mobile, or bench-top devices. Its inaugural application focuses on a non-invasive continuous blood glucose monitoring device designed to offer real-time data on blood glucose levels. This innovation is set to aid the management of diabetes and prediabetes for millions of individuals. Notably, Know Labs is a public company with shares trading under the stock symbol KNW on the NYSE American.
Founded in 2003 and headquartered in the United States, Know Labs recently secured a $4.00M post-IPO debt investment on 29 February 2024. This investment came from The Lind Partners, LLC, marking a significant milestone for the company's growth and development in the field of non-invasive medical diagnostics.